Neuroreport · 2002 · 223 citations · 20 references
Life SciencesNeurologyNeuroscienceDementiaLipid BiochemistryNeurodegenerationAlzheimer DiseaseCholesterol MetabolismLipid DisordersLipid MetabolismLipid-lowering TherapyLipoprotein MetabolismDietary CholesterolLipid Metabolism AlterationsLipid Response To DietPlasma Cholesterol LevelsTriglyceride-rich Lipoproteins
Epidemiological data show correlations between hypercholesterolemia and Alzheimer's disease (AD). We test the hypothesis that hypercholesterolemia modulates Abeta deposition in mice overexpressing the human APP695 Swedish mutation (K670N and M671L) (TgAPPsw). Feeding mice a high fat/high cholesterol (HFHC) diet for 7-10 months increased total cholesterol levels by 4-fold. The extent of Abeta immunostained plaque-like deposits were significantly higher for mice fed the HFHC diet as compared with mice fed rodent chow. Extent of deposits correlated inversely with plasma levels of HDL and directly to apolipoprotein E. Overall, plasma lipoproteins may be an important factor in induction of AD-like plaques in mice. The lowering of plasma lipids may be therapeutic for AD patients.
20
Mikael Simons, Christine Bergmann, Mark Stroick et al. · Proceedings of the National Academy of Sciences · 2001 · 1.1K citations · Full text
Variation in susceptibility to atherosclerosis among inbred strains of mice
Beverly Paigen, Ardythe L. Morrow, Charles W. Brandon et al. · Atherosclerosis · 1985 · 611 citations